180 Fenglin Road
Shanghai, 200032, China
NCT Number: NCT04505384
The study was designed to compare the acute effects of left bundle branch pacing (LBBP) with biventricular pacing (BVP) in patients with left ventricular ejection fraction (LVEF) <=35% with left bundle branch block (LBBB).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Shanghai, 200032, China
The metrics include electrocardiographic, echocardiographic and hemodynamic parameters to evaluate and compare LBBP with BVP for resynchronization therapy in patients with heart failure and LBBB.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
left bundle branch pacing
biventricular pacing
Time frame: 1 hour
LV dP/dt(max) will be obtained during implant procedure.
Time frame: 0.5 hour
Acquired from EP system during procedure
Time frame: 0.5 hour
Acquired by an echocardiologist during procedure
Shanghai Zhongshan Hospital
Other
Acute Effects of Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03587064
Cardiac Resynchronization Therapy, Cardiovascular Diseases
Ancona, Italy
View Trial DetailsNCT03012490
Cardiac Resynchronization Therapy, Cardiovascular Diseases
Lille, France
View Trial DetailsNCT03839121
Cardiac Resynchronization Therapy, Cardiovascular Diseases
Linz, Austria
View Trial DetailsNCT03579641
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Birmingham, Alabama, United States
View Trial Details